ASGCT Annual Meetings 2022-24: Travel Awards and Underrepresented Minority Travel Awards

2022-24 年 ASGCT 年会：旅行奖和代表性不足的少数族裔旅行奖

• 批准号: 10614034
• 负责人: David Barrett
• 金额: $ 1.5万
• 依托单位: AMERICAN SOCIETY OF GENE & CELL THERAPY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-05-01 至 2025-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10614034
• 关键词: American; Award; Awareness; Cell Therapy; Chronic Disease; Clinical Trials; Databases; Development; Disease; Education; Event; Funding; Future; Goals; Grant; Improve Access; Individual; Industry; Institution; Investments; Knowledge; Learning; Mission; Outcome; Positioning Attribute; Postdoctoral Fellow; Public Health; Rare Diseases; Reporting; Research; Research Personnel; Running; Societies; Students; Travel; Underrepresented Minority; Underrepresented Populations; United States National Institutes of Health; career; clinical application; clinical development; cost; diversity and inclusion; experience; fortification; gene therapy; human disease; meeting abstracts; meetings; member; product development; research and development; success

American Society of Gene and Cell Therapy PA-21-151 PROJECT SUMMARY This application by The American Society of Gene and Cell Therapy (ASGCT) requests $15,000 for 10 travels award and 20 underrepresented minority travel awards ($500 per award) for students and post-doctoral fellows to attend the ASGCT Annual Meetings in 2022, 2023, and 2024—for a total of $45,000 and 90 travel awards. To determine awards, ASGCT run a report from our abstract presenter database that pools abstract applicants who are students or post-doctoral fellows. Those with the top 15 scoring abstracts receive an Excellence in Research Award (not supported by this grant), and those scoring over 3.5 receive a $500 travel award (such as those supported by this grant). Then, remaining applicants who identify as underrepresented individuals are ranked by score, and the top 20 are given travel awards (also to be supported by this grant). ASGCT abides strictly by the NIH’s definition of underrepresentation populations in selecting awardees. ASGCT’s mission is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. This project bolsters our mission by supporting early-career professional to travel to our Annual Meetings to gain exposure for their research, thereby advancing knowledge and spurning professional development that will better position those early-career professionals to make discoveries and produce clinical applications in the future.

美国基因与细胞治疗学会